Annual Operating Expenses
$8.52 M
-$427.40 K-4.78%
30 June 2024
Summary:
NanoViricides annual total operating expenses is currently $8.52 million, with the most recent change of -$427.40 thousand (-4.78%) on 30 June 2024. During the last 3 years, it has fallen by -$228.00 thousand (-2.61%). NNVC annual operating expenses is now -11.30% below its all-time high of $9.60 million, reached on 30 June 2017.NNVC Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Expenses
$3.17 M
+$776.40 K+32.47%
01 September 2024
Summary:
NanoViricides quarterly total operating expenses is currently $3.17 million, with the most recent change of +$776.40 thousand (+32.47%) on 01 September 2024. Over the past year, it has increased by +$983.00 thousand (+44.99%). NNVC quarterly operating expenses is now -16.50% below its all-time high of $3.79 million, reached on 30 June 2014.NNVC Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NNVC Operating Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -4.8% | +45.0% |
| 3 y3 years | -2.6% | +64.9% |
| 5 y5 years | -1.7% | +93.8% |
NNVC Operating Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -4.8% | +5.0% | -13.8% | +95.3% |
| 5 y | 5 years | -4.8% | +6.5% | -13.8% | +95.3% |
| alltime | all time | -11.3% | >+9999.0% | -16.5% | +681.8% |
NanoViricides Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $3.17 M(+32.5%) |
| June 2024 | $8.52 M(-4.8%) | $2.39 M(+25.3%) |
| Mar 2024 | - | $1.91 M(-12.7%) |
| Dec 2023 | - | $2.18 M(+7.5%) |
| Sept 2023 | - | $2.03 M(-44.7%) |
| June 2023 | $8.94 M(+10.2%) | $3.68 M(+103.0%) |
| Mar 2023 | - | $1.81 M(-1.3%) |
| Dec 2022 | - | $1.83 M(+13.0%) |
| Sept 2022 | - | $1.62 M(-9.5%) |
| June 2022 | $8.11 M(-7.2%) | $1.79 M(+0.3%) |
| Mar 2022 | - | $1.79 M(-6.9%) |
| Dec 2021 | - | $1.92 M(-26.5%) |
| Sept 2021 | - | $2.61 M(+25.9%) |
| June 2021 | $8.74 M(+9.3%) | $2.07 M(-1.6%) |
| Mar 2021 | - | $2.11 M(-8.0%) |
| Dec 2020 | - | $2.29 M(+0.9%) |
| Sept 2020 | - | $2.27 M(+23.9%) |
| June 2020 | $8.00 M(-7.7%) | $1.83 M(-27.9%) |
| Mar 2020 | - | $2.54 M(+55.6%) |
| Dec 2019 | - | $1.63 M(-17.8%) |
| Sept 2019 | - | $1.99 M(-8.3%) |
| June 2019 | $8.66 M(-7.1%) | $2.17 M(+4.1%) |
| Mar 2019 | - | $2.08 M(-12.1%) |
| Dec 2018 | - | $2.37 M(+16.2%) |
| Sept 2018 | - | $2.04 M(-10.7%) |
| June 2018 | $9.33 M(-2.9%) | $2.28 M(-5.6%) |
| Mar 2018 | - | $2.42 M(+1.0%) |
| Dec 2017 | - | $2.39 M(+7.3%) |
| Sept 2017 | - | $2.23 M(-0.7%) |
| June 2017 | $9.60 M(+8.4%) | $2.25 M(-14.1%) |
| Mar 2017 | - | $2.62 M(+13.8%) |
| Dec 2016 | - | $2.30 M(-5.9%) |
| Sept 2016 | - | $2.44 M(-2.2%) |
| June 2016 | $8.86 M(+25.4%) | $2.50 M(+21.9%) |
| Mar 2016 | - | $2.05 M(-2.0%) |
| Dec 2015 | - | $2.09 M(-6.1%) |
| Sept 2015 | - | $2.23 M(-14.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2015 | $7.06 M(-18.5%) | $2.60 M(+131.8%) |
| Mar 2015 | - | $1.12 M(-34.1%) |
| Dec 2014 | - | $1.70 M(+1.0%) |
| Sept 2014 | - | $1.69 M(-55.5%) |
| June 2014 | $8.67 M(+31.5%) | $3.79 M(+207.6%) |
| Mar 2014 | - | $1.23 M(-29.6%) |
| Dec 2013 | - | $1.75 M(-7.3%) |
| Sept 2013 | - | $1.89 M(+20.9%) |
| June 2013 | $6.59 M(+8.4%) | $1.56 M(-28.7%) |
| Mar 2013 | - | $2.19 M(+76.1%) |
| Dec 2012 | - | $1.24 M(-21.8%) |
| Sept 2012 | - | $1.59 M(+2.8%) |
| June 2012 | $6.08 M(-5.4%) | $1.55 M(-25.5%) |
| Mar 2012 | - | $2.08 M(+55.3%) |
| Dec 2011 | - | $1.34 M(+17.2%) |
| Sept 2011 | - | $1.14 M(-9.6%) |
| June 2011 | $6.43 M(+30.2%) | $1.26 M(-50.7%) |
| Mar 2011 | - | $2.56 M(+70.6%) |
| Dec 2010 | - | $1.50 M(+34.9%) |
| Sept 2010 | - | $1.11 M(+29.8%) |
| June 2010 | $4.94 M(+75.2%) | $856.20 K(-64.7%) |
| Mar 2010 | - | $2.43 M(+161.7%) |
| Dec 2009 | - | $926.60 K(+26.6%) |
| Sept 2009 | - | $732.10 K(+16.9%) |
| June 2009 | $2.82 M(+1.0%) | $626.40 K(-20.9%) |
| Mar 2009 | - | $792.00 K(+22.9%) |
| Dec 2008 | - | $644.50 K(-14.8%) |
| Sept 2008 | - | $756.80 K(-24.2%) |
| June 2008 | $2.79 M(-9.4%) | $998.90 K(+24.0%) |
| Mar 2008 | - | $805.30 K(+98.7%) |
| Dec 2007 | - | $405.20 K(-30.4%) |
| Sept 2007 | - | $582.60 K(-24.8%) |
| June 2007 | $3.08 M(+18.8%) | $774.90 K(-16.5%) |
| Mar 2007 | - | $928.40 K(+31.4%) |
| Dec 2006 | - | $706.60 K(+5.0%) |
| Sept 2006 | - | $673.00 K |
| June 2006 | $2.60 M(+3833.0%) | - |
| June 2005 | $66.00 K | - |
FAQ
- What is NanoViricides annual total operating expenses?
- What is the all time high annual operating expenses for NanoViricides?
- What is NanoViricides annual operating expenses year-on-year change?
- What is NanoViricides quarterly total operating expenses?
- What is the all time high quarterly operating expenses for NanoViricides?
- What is NanoViricides quarterly operating expenses year-on-year change?
What is NanoViricides annual total operating expenses?
The current annual operating expenses of NNVC is $8.52 M
What is the all time high annual operating expenses for NanoViricides?
NanoViricides all-time high annual total operating expenses is $9.60 M
What is NanoViricides annual operating expenses year-on-year change?
Over the past year, NNVC annual total operating expenses has changed by -$427.40 K (-4.78%)
What is NanoViricides quarterly total operating expenses?
The current quarterly operating expenses of NNVC is $3.17 M
What is the all time high quarterly operating expenses for NanoViricides?
NanoViricides all-time high quarterly total operating expenses is $3.79 M
What is NanoViricides quarterly operating expenses year-on-year change?
Over the past year, NNVC quarterly total operating expenses has changed by +$983.00 K (+44.99%)